Nils Nyhlin
- Gastroenterology top 5%
- Dermatology top 5%
- Hidradenitis Suppurativa and Treatments 8
- Hepatology top 5%
- Liver Diseases and Immunity 11
- Epidemiology top 5%
- Microscopic Colitis 16
- Liver Disease Diagnosis and Treatment 10
- Neuroendocrine Tumor Research Advances 4
- Genetics top 5%
- Inflammatory Bowel Disease 16
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 9
-
- Gastric Cancer Management and Outcomes 5
- Journals
- Scandinavian Journal of Gastroenterology (8 papers)Alimentary Pharmacology & Therapeutics (4 papers)Journal of Internal Medicine (4 papers)
- Partner nations
- SwedenJapanUnited Kingdom
In The Last Decade
Nils Nyhlin
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Gastroenterology 108
- Dermatology 166
- Hepatology 145
- Epidemiology 563
- Genetics 357
Countries citing papers authored by Nils Nyhlin
This map shows the geographic impact of Nils Nyhlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Nyhlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Nyhlin more than expected).
Fields of papers citing papers by Nils Nyhlin
This network shows the impact of papers produced by Nils Nyhlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Nyhlin. The network helps show where Nils Nyhlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nils Nyhlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 31 | |
| 6 | 2018 | 33 | |
| 7 | 2018 | 17 | |
| 8 | 2017 | 40 | |
| 9 | 2015 | 25 | |
| 10 | 2015 | 31 | |
| 11 | IL-1/TLR signaling inhibitors in microscopic and ulcerative colitis : Immunopathogenic markers of active disease and remission | 2013 | 1 |
| 12 | 2013 | 43 | |
| 13 | 2008 | 19 | |
| 14 | 2006 | 78 | |
| 15 | 2002 | 9 | |
| 16 | 2000 | 13 | |
| 17 | 1999 | 17 | |
| 18 | 1999 | 23 | |
| 19 | 1997 | 8 | |
| 20 | 1996 | 61 |
About Nils Nyhlin
Nils Nyhlin is a scholar working on Hepatology, Dermatology and Epidemiology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (16 papers), Liver Diseases and Immunity (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Hidradenitis Suppurativa and Treatments (8 papers), Gastric Cancer Management and Outcomes (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Gastroenterology (108 citations), Dermatology (166 citations) and Hepatology (145 citations). Nils Nyhlin has collaborated with scholars based in Sweden, Japan and United Kingdom. Frequent co-authors include Curt Tysk, Johan Bohr, Ole B. Suhr, Anna Wickbom, Yukio Ando, Sune Eriksson, S. Eriksson, Kôji Uchida, Scott Montgomery and Taro Yamashita. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics, Journal of Internal Medicine, Inflammatory Bowel Diseases and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.